Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation
Oncology Reports · 2025
DOI: 10.3892/or.2025.8880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Yasutoshi Tatsumi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan. Hauptthemen laut MEDLINE: Osteosarcoma, Curcumin, Bone Neoplasms, Histones. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.
- Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
- Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260‑8717, Japan.
Zitieren
APA
Tatsumi, Y., Masuda, T., Watanabe, T., Utomo, R. Y., Zulfin, U. M., Meiyanto, E., Ozaki, T., Suenaga, Y., & Kamikubo, Y. (2025). Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation. Oncology Reports. https://doi.org/10.3892/or.2025.8880
Vancouver
Tatsumi Y, Masuda T, Watanabe T, Utomo RY, Zulfin UM, Meiyanto E, et al. Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation. Oncology Reports. 2025. doi:10.3892/or.2025.8880
BibTeX
@article{Tatsumi2025,
author = {Tatsumi, Yasutoshi and Masuda, Tatsuya and Watanabe, Takayoshi and Utomo, Rohmad Yudi and Zulfin, Ummi Maryam and Meiyanto, Edy and Ozaki, Toshinori and Suenaga, Yusuke and Kamikubo, Yasuhiko},
title = {Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.8880}
}
EUVIMED